Articles
-
2 weeks ago |
tradingview.com | Anthony Goriainoff
Tap Global to List on London's Junior AIMTap Global said it plans to list on London's junior AIM later in the month. The regulated cryptocurrency app said Friday that it wasn't raising any new capital nor would it be providing a secondary offering as part of the admission. The company said it had 743.4 million ordinary shares in issue at present. The board said that AIM was a more appropriate market for the company, allowing it to attract a wider set of investors and improve liquidity over time.
-
3 weeks ago |
morningstar.com | Anthony Goriainoff
By Anthony O. Goriainoff AIB Group plans to sell its stake in the AIB Merchant Services joint venture to its partner Fiserv for an undisclosed amount. The Irish lender on Friday said the sale of its 49.9% shareholding in AIBMS is expected to result in a positive effect of around 35 basis points on its CET1 capital--a key component of a bank's regulatory capital requirements. AIB said it would continue to work with AIBMS and Fiserv by referring customers requiring merchant card services.
-
3 weeks ago |
wsj.com | Anthony Goriainoff
British American Tobacco BATS 0.24%increase; green up pointing triangle said revenue in the first half was slightly better than expected, and raised its outlook for the year. The FTSE 100 tobacco group on Tuesday said it now expects to deliver revenue growth for the first half and the year of 1% to 2% at constant rates, up from a prior 1%. The company reported revenue of 25.87 billion pounds ($35.04 billion) for 2024. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved.
-
1 month ago |
wsj.com | Anthony Goriainoff
Trials showed statistically significant progression-free survival results, GSK saidGSK said combinations of its blood-cancer treatment, Blenrep, have been approved by Japan’s Ministry of Health, and that it expects more approvals through the year. The U.K. pharma company said Monday that the combinations were approved for the treatment of adults with relapsed or refractory multiple myeloma, and that this was the second major approval for the Blenrep combinations.
-
1 month ago |
wsj.com | Anthony Goriainoff
Nissan said sales dropped 4.3%, dragged by falls in China, Japan and EuropeThe French automobile group—which holds 35.71% of Nissan’s share capital—on Tuesday said the negative contribution included the impairments and restructuring costs necessary for the Japanese automaker’s effective turnaround initiatives announced on April 24.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →